Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginger and the Microbiota-gut-brain Connection in Sciatic Pain
NCT06817018Phase 2Recruiting
- Start
- Jul 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sciatica comparing Placebo with Ginger (2 arms). Primary endpoints: Plasma lipopolysaccharide binding protein at 8 weeks, Fecal zonulin at 8 weeks and 2 more. Started Jul 2025; status: recruiting.
02
Drugs
ginger
03
Conditions
Sciatica
Beyond the preview
Go deeper on NCT06817018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06817018.